Related Experiment Video
Updated: Sep 15, 2025

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Recurrent Systemic Embolization in a Patient With Aortic Valve Amyloidosis
Annalisa Caputo1, Amedeo Pergolini2, Luigi Monticelli3
1Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
A rare case highlights aortic valve thrombosis due to isolated aortic valve amyloidosis in a patient with antiphospholipid syndrome. This rare condition led to recurrent thromboembolic events, including STEMI and limb ischemia.
Area of Science:
- Cardiology
- Hematology
- Pathology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of thrombosis.
- Aortic valve amyloidosis is a rare condition characterized by the deposition of amyloid protein in the aortic valve.
Observation:
- A 47-year-old woman presented with recurrent thromboembolic events, including ST-elevation myocardial infarction (STEMI) and lower limb ischemia.
- Diagnostic workup revealed aortic valve thrombosis.
Findings:
- The aortic valve thrombosis was attributed to isolated aortic valve amyloidosis.
- The patient had overlapping antiphospholipid syndrome, complicating the clinical picture.
Implications:
- This case underscores the importance of considering rare causes of aortic valve thrombosis in patients with recurrent thromboembolic events and APS.
- Early diagnosis and management are crucial to prevent severe cardiovascular complications.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

